HMA-EMA joint Network Data Steering Group meeting - 17 July 2025

List of signals discussed at PRAC since September 2012

PRAC recommendations on signals adopted at the 1-4 September 2025 PRAC meeting

New product information wording: extracts from PRAC recommendations on signals adopted at the 1-4 September 2025 PRAC

Human medicines European public assessment report (EPAR): Blitzima, rituximab, Date of authorisation: 13/07/2017, Revision: 24, Status: Authorised

A path to better include patients’ perspectives in the regulation of medicines

Human medicines European public assessment report (EPAR): Ibandronic acid Accord, ibandronic acid, Date of authorisation: 18/11/2012, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Tigecycline Accord, tigecycline, Date of authorisation: 17/04/2020, Revision: 7, Status: Authorised

Minutes of the COMP meeting 15-17 July 2025

Enpr-EMA Coordinating Group and networks meeting June 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, 11 June 2025